Gimoti FDA Approval History
FDA Approved: Yes (First approved June 19, 2020)
Brand name: Gimoti
Generic name: metoclopramide
Dosage form: Nasal Spray
Company: Evoke Pharma, Inc.
Treatment for: Gastroparesis
Gimoti (metoclopramide) is an intranasal formulation of the approved drug metoclopramide for the relief of symptoms of acute and recurrent diabetic gastroparesis in adults.
Development Timeline for Gimoti
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.